A. Lazarus et al., CARDIAC-ARRHYTHMIAS IN THE ADULT SHEEP AP NEA SYNDROME, Archives des maladies du coeur et des vaisseaux, 86(12), 1993, pp. 1753-1759
Many nocturnal cardiac arrhythmias and conduction defects have been re
ported in the adult sleep apnoea syndrome. The most original is the gr
eat variability of the heart rate which is cyclical and related to the
apnoeic episodes, and easily differentiated from simple respiratory s
inus arrhythmia. It is characterised by an initial bradycardia followe
d by rebound tachycardia. The bradycardia is vagally dependant (inhibi
ted by atropine) probably secondary to carotid chemoreceptor stimulati
on by the hypoxaemia. The tachycardia is mainly attributed to the cess
ation of vagal hypertonicity although catecholamine stimulation has be
en suggested. The origin of these changes is purely functional, regres
sing with treatment of apnoea (waking, tracheotomy), the maintenance o
f arterial oxygen concentrations with oxygen therapy and parasympathet
ic blockade (atropine). The intensity of the phenomenon is related to
the degree of arterial desaturation, which is itself related to basal
arterial saturation (SaO2) and the duration of the apnoeas. Prolonged
systole due to paroxysmal sino-atrial or atrioventricular block may be
observed at night in these patients. The influence of vagal overactiv
ity is confirmed (suppression of vagotomy) with no organic pathology (
diurnal absence, tracheotomy, normal electrophysilogical testing) in f
avour of a relationship with apnoea. Though less common than conductio
n abnormalities, atrial arrhythmias (extrasystoles, flutter, fibrillat
ion) are also possible complications of sleep apnoea. The absence of a
n organic substrate is indicated by their regression post-tracheotomy
and the efficacy of atropine (again in favour of a vagally-induced mec
hanism). Finally, noctumal ventricular hyper-excitability is sometimes
observed, the probable mechanism being the association of severe hypo
xaemias (SaO2 < 60 %) and the increased sympathetic tone at the end of
the apnoea. This poses the problem of possible underlying ischaemic h
eart disease with acute myocardial ischaemia caused by the fall in SaO
2 which, in association with catecholamine release, could induce extra
systoles, episodes of ventricular tachycardia or even fibrillation. Al
l these noctumal abnormalities may be recorded by Holter ECG and shoul
d enable a firm diagnosis of the sleep apnoea syndrome.